| scholarly article | Q13442814 |
| P50 | author | Emmanuelle Liaudet-Coopman | Q74519771 |
| P2093 | author name string | Christine Prébois | |
| Nobuhiko Katunuma | |||
| Danielle Derocq | |||
| Valérie Laurent-Matha | |||
| P2860 | cites work | Isolation and characterization of a stable activation intermediate of the lysosomal aspartyl protease cathepsin D | Q28292267 |
| Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells | Q28295485 | ||
| Evolution in the structure and function of aspartic proteases | Q28300400 | ||
| Neuronal loss and brain atrophy in mice lacking cathepsins B and L | Q34030250 | ||
| Enhanced degradation of cathepsin D synthesized in the presence of the threonine analog beta-hydroxynorvaline | Q34259894 | ||
| Multiple functions of pro-parts of aspartic proteinase zymogens | Q34339858 | ||
| Processing and activation of lysosomal proteinases | Q35055169 | ||
| Catalytically inactive human cathepsin D triggers fibroblast invasive growth | Q36321336 | ||
| Proteolytic Activation of Human Procathepsin D | Q37041771 | ||
| Human prorenin | Q37687876 | ||
| Lysosomal enzyme targeting | Q37886057 | ||
| Mannose 6-phosphate-independent targeting of cathepsin D to lysosomes in HepG2 cells | Q38331833 | ||
| Structural evidence for gene duplication in the evolution of the acid proteases | Q39183165 | ||
| Lysosomal enzymes and their receptors | Q39479416 | ||
| A replacement of the active-site aspartic acid residue 293 in mouse cathepsin D affects its intracellular stability, processing and transport in HEK-293 cells | Q40701217 | ||
| Specific mannose-6-phosphate receptor-independent sorting of pro-cathepsin D in breast cancer cells | Q41431024 | ||
| Structural requirements of procathepsin D activation and maturation | Q41467286 | ||
| Autocrine growth stimulation of the MCF 7 breast cancer cells by the estrogen-regulated 52 K protein. | Q41492398 | ||
| Biosynthesis of lysosomal enzymes in fibroblasts. Synthesis as precursors of higher molecular weight. | Q41926788 | ||
| Effects of cysteine protease inhibitors on rabbit cathepsin D maturation | Q41945044 | ||
| Molecular aspects of the endocytic pathway | Q42992153 | ||
| A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. | Q43785805 | ||
| CA-074, but not its methyl ester CA-074Me, is a selective inhibitor of cathepsin B within living cells | Q44219923 | ||
| Intracellular and extracellular cathepsin B facilitate invasion of MCF-10A neoT cells through reconstituted extracellular matrix in vitro | Q44312060 | ||
| Cathepsin L is involved in cathepsin D processing and regulation of apoptosis in A549 human lung epithelial cells | Q45023221 | ||
| Endocytosis of pro-cathepsin D into breast cancer cells is mostly independent of mannose-6-phosphate receptors. | Q47695846 | ||
| Mechanisms and kinetics of procathepsin D activation | Q47851176 | ||
| Lysosomal enzyme precursors in human fibroblasts. Activation of cathepsin D precursor in vitro and activity of beta-hexosaminidase A precursor towards ganglioside GM2. | Q47860602 | ||
| Carboxyl-terminal proteolytic processing during biosynthesis of the lysosomal enzymes .beta.-glucuronidase and cathepsin D | Q49487167 | ||
| Processing of human cathepsin D in lysosomes in vitro. | Q54453142 | ||
| Proteolytic processing sites producing the mature form of human cathepsin D | Q67576241 | ||
| Effect of tunicamycin and endoglycosidase H and F on the estrogen regulated 52000-Mr protein secreted by breast cancer cells | Q69982982 | ||
| Procathepsin D cannot autoactivate to cathepsin D at acid pH | Q70612684 | ||
| Role of glycosylation in the expression of human procathepsin D | Q72017227 | ||
| Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo | Q73077056 | ||
| Proteases as prognostic markers in cancer | Q77556803 | ||
| Intramolecular activation of porcine pepsinogen | Q93696517 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 363-371 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Journal of Biochemistry | Q6294839 |
| P1476 | title | Processing of human cathepsin D is independent of its catalytic function and auto-activation: involvement of cathepsins L and B | |
| P478 | volume | 139 |
| Q91920794 | A family of PIKFYVE inhibitors with therapeutic potential against autophagy-dependent cancer cells disrupt multiple events in lysosome homeostasis |
| Q47838298 | Activation of cathepsin D by glycosaminoglycans |
| Q45383467 | Analyses of the spleen proteome of chickens infected with Marek's disease virus |
| Q92309600 | Cathepsin B pH-Dependent Activity Is Involved in Lysosomal Dysregulation in Atrophic Age-Related Macular Degeneration |
| Q35840138 | Cathepsin D inhibitors as potential therapeutics for breast cancer treatment: Molecular docking and bioevaluation against triple-negative and triple-positive breast cancers |
| Q47305008 | Cathepsin D regulates cathepsin B activation and disease severity predominantly in inflammatory cells during experimental pancreatitis. |
| Q34582202 | Cathepsin D: Regulation in mammary gland remodeling, misregulation in breast cancer |
| Q37724780 | Cathepsin L in metastatic bone disease: therapeutic implications |
| Q37735722 | Cathepsin L in tumor angiogenesis and its therapeutic intervention by the small molecule inhibitor KGP94. |
| Q36723297 | Cathepsin L inactivation leads to multimodal inhibition of prostate cancer cell dissemination in a preclinical bone metastasis model. |
| Q37296811 | Cathepsin L inhibition by the small molecule KGP94 suppresses tumor microenvironment enhanced metastasis associated cell functions of prostate and breast cancer cells |
| Q36218199 | Cathepsin L targeting in cancer treatment. |
| Q37161711 | Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential |
| Q43576179 | Changes in Proteases, Antiproteases and Bioactive Proteins From Mother's Breast Milk to the Premature Infant Stomach. |
| Q41116581 | Chronic cathepsin inhibition by E-64 in Dahl salt-sensitive rats. |
| Q38079586 | Cystatins in immune system |
| Q26747530 | Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets |
| Q41063731 | Expression and Localization of Cathepsins B, D, and G in Two Cancer Stem Cell Subpopulations in Moderately Differentiated Oral Tongue Squamous Cell Carcinoma |
| Q94586186 | Genetic perspective on the synergistic connection between vesicular transport, lysosomal and mitochondrial pathways associated with Parkinson's disease pathogenesis |
| Q90748702 | Heterologous expression and characterization of the aspartic endoprotease Pep4um from Ustilago maydis, a homolog of the human Chatepsin D, an important breast cancer therapeutic target |
| Q41233173 | Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis |
| Q26749121 | Lysosomal cathepsins and their regulation in aging and neurodegeneration |
| Q38821869 | Mahogunin regulates fusion between amphisomes/MVBs and lysosomes via ubiquitination of TSG101. |
| Q91889034 | Mesenchymal stem cell homing towards cancer cells is increased by enzyme activity of cathepsin D |
| Q35922605 | Neutrophil gelatinase-associated lipocalin (NGAL) expression is dependent on the tumor-associated sigma-2 receptor S2RPgrmc1. |
| Q52559939 | Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process. |
| Q34242086 | Pro-cathepsin D interacts with the extracellular domain of the beta chain of LRP1 and promotes LRP1-dependent fibroblast outgrowth. |
| Q34402583 | Proteomic Identification of Cathepsin B and Nucleophosmin as Novel UVA‐Targets in Human Skin Fibroblasts |
| Q39174473 | Regulation of hepatitis B virus infection by Rab5, Rab7, and the endolysosomal compartment. |
| Q98184087 | Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis |
| Q91879301 | Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase |
| Q97557237 | The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management |
| Q28484433 | The Ionic and hydrophobic interactions are required for the auto activation of cysteine proteases of Plasmodium falciparum |
| Q26776510 | The Potential Role of the Proteases Cathepsin D and Cathepsin L in the Progression and Metastasis of Epithelial Ovarian Cancer |
| Q37406971 | The biology of cystatin M/E and its cognate target proteases. |
| Q64767459 | The role of Rab GTPases in the pathobiology of Parkinson' disease |
| Q91662958 | The role of cathepsin D in the pathophysiology of heart failure and its potentially beneficial properties: a translational approach |
| Q51741603 | Trace levels of the CHO host cell protease cathepsin D caused particle formation in a monoclonal antibody product. |
| Q47108521 | Urinary peptidomics analysis reveals proteases involved in diabetic nephropathy. |
| Q39208117 | Yeast as a tool to explore cathepsin D function |
Search more.